iShares Biotechnology ETF

IBB · ETF

$207.74−$1.80 (−0.86%)TodayMarket closed ·
Prev close $209.54

Latest news

  • News

    Reported October 22, U.S. Treasury Department Issues Notice Of Proposed Rulemaking For The Outbound Investment Security Program Under The COINS Act; Secretary Has Added Biotechnology To Proposed Regulations

  • NewsPiero Cingari

    Dow Jones Climbs to 52,000 While Chips Bleed on Rate-Hike Fears: Stock Market Today

  • NewsPiero Cingari

    Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today

  • NewsPiero Cingari

    Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%

  • NewsPiero Cingari

    S&P 500, Nasdaq Hit Records, Power Stocks Rally on Google's Nuclear Deal: Stock Market Today

  • NewsPiero Cingari

    S&P 500 Erases Losses as US, Iran Reportedly Discuss Hormuz Deal: Stock Market Today

  • NewsPiero Cingari

    Nasdaq 100 Flirts with Records, Oil Sinks for Fifth Day: Stock Market Today

  • NewsPiero Cingari

    Nasdaq 100 Rallies as Oil Slides, Yields Retreat: Stock Market Today

  • NewsPiero Cingari

    S&P 500 Gains, Crude Falls Ahead Of Fed's Expected First Hike Since 2023: Stock Market Today

  • NewsPiero Cingari

    QUICK SPARK: Amgen Stock Eyes Worst Day Since October 2000

  • NewsPiero Cingari

    S&P 500, Nasdaq Slip as $98 Brent Reignites Inflation Fears: Stock Market Today

  • NewsVandana Singh

    What's Going On With Amgen Stock Tuesday?

  • NewsPiero Cingari

    Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today

  • NewsChandrima Sanyal

    Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

  • NewsPiero Cingari

    Memory Stocks Slide as Trump Threatens 50% Tariffs on Canadian Autos, Steel in 2027: Stock Market Today

  • NewsPiero Cingari

    Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today

  • NewsErica Kollmann

    Biotech Is Booming, But These 2 Stocks Missed the Memo

  • NewsChandrima Sanyal

    Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For

  • NewsPiero Cingari

    Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today

  • NewsStjepan Kalinic

    ‘Never Happened in History,’ Ex-Bridgewater Exec Warns AI Market Is Priced to Perfection

  • NewsPiero Cingari

    Oil Jumps 3%, Yields Climb as Hormuz Hopes Fade: Stock Market Today

  • NewsVandana Singh

    Moderna Advances Ebola Vaccine Into Human Testing

  • NewsPiero Cingari

    Chip Rout Drags Nasdaq 100, Oil Sinks Below $69: Stock Market Today

  • NewsVandana Singh

    Why Is Natera Stock Gaining Tuesday?

  • NewsPiero Cingari

    Chip Bloodbath Hits Nasdaq 100 As South Korea Plunges: Stock Market Today

  • NewsChandrima Sanyal

    Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF

  • NewsPiero Cingari

    Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows

  • NewsVandana Singh

    Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion

  • NewsPiero Cingari

    Nasdaq 100 Hits Record Above 30,000 On Micron's 18% Rally: Stock Market Today

  • NewsPiero Cingari

    Nasdaq 100 Falls 1% As 30-Year Yields Spike To 19-Year Highs: Stock Market Today

  • NewsPiero Cingari

    Stock Market Today: Oil Jumps 5%, S&P 500 Drops As Iran Strikes UAE Port

  • NewsPiero Cingari

    Nasdaq 100 Eases From Records As Software Stocks Plunge: Stock Market Today

  • NewsHillary Remy

    The Year-End 2025 Biotech Rally And What It Means For 2026

  • NewsPiero Cingari

    The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly

  • NewsAkanksha Bakshi

    Enpro Moves To Boost Profits With $280 Million Acquisition Push

  • NewsChandrima Sanyal

    How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.